Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.

Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, Gammon MD, Douglas Thompson W, Bernstein JL.

Breast Cancer Res Treat. 2011 Nov;130(2):587-97. doi: 10.1007/s10549-011-1616-x. Epub 2011 Jun 11.

2.

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors.

Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS, Lee MM, Ambrosone CB, Caan BJ.

Breast Cancer Res. 2009;11(3):R31. doi: 10.1186/bcr2261. Epub 2009 May 22.

3.

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, Perou CM, Ellis MJ, Nielsen TO.

J Natl Cancer Inst. 2009 May 20;101(10):736-50. doi: 10.1093/jnci/djp082. Epub 2009 May 12.

4.

Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.

Phipps AI, Malone KE, Porter PL, Daling JR, Li CI.

Cancer. 2008 Oct 1;113(7):1521-6. doi: 10.1002/cncr.23786.

5.

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.

Tamimi RM, Baer HJ, Marotti J, Galan M, Galaburda L, Fu Y, Deitz AC, Connolly JL, Schnitt SJ, Colditz GA, Collins LC.

Breast Cancer Res. 2008;10(4):R67. doi: 10.1186/bcr2128. Epub 2008 Aug 5.

6.

Comparison of estrogen receptor results from pathology reports with results from central laboratory testing.

Collins LC, Marotti JD, Baer HJ, Tamimi RM.

J Natl Cancer Inst. 2008 Feb 6;100(3):218-21. doi: 10.1093/jnci/djm270. Epub 2008 Jan 29.

7.

Epidemiology of basal-like breast cancer.

Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM.

Breast Cancer Res Treat. 2008 May;109(1):123-39. Epub 2007 Jun 20. Erratum in: Breast Cancer Res Treat. 2008 May;109(1):141. Dressler, Lynn G [added].

8.

Differences in risk factors for breast cancer molecular subtypes in a population-based study.

Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, García-Closas M.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):439-43.

10.

Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism.

Glynn RJ, Rosner B.

Am J Epidemiol. 2005 Nov 15;162(10):975-82. Epub 2005 Oct 5.

PMID:
16207808
11.

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

Brenton JD, Carey LA, Ahmed AA, Caldas C.

J Clin Oncol. 2005 Oct 10;23(29):7350-60. Epub 2005 Sep 6. Review.

PMID:
16145060
12.

The Nurses' Health Study: lifestyle and health among women.

Colditz GA, Hankinson SE.

Nat Rev Cancer. 2005 May;5(5):388-96. Review.

PMID:
15864280
13.
14.
15.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

PMID:
15601642
16.

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.

Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM.

Clin Cancer Res. 2004 Aug 15;10(16):5367-74.

17.

Expression of luminal and basal cytokeratins in human breast carcinoma.

Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO.

J Pathol. 2004 Jun;203(2):661-71.

PMID:
15141381
18.

Methods to evaluate risks for composite end points and their individual components.

Glynn RJ, Rosner B.

J Clin Epidemiol. 2004 Feb;57(2):113-22.

PMID:
15125620
19.

Risk factors for breast cancer according to estrogen and progesterone receptor status.

Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE.

J Natl Cancer Inst. 2004 Feb 4;96(3):218-28.

PMID:
14759989
20.

Repeated observation of breast tumor subtypes in independent gene expression data sets.

Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale AL, Botstein D.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23. Epub 2003 Jun 26.

Supplemental Content

Support Center